Evaluation of serum Midkine as a novel biomarker for the diagnosis of hepatocellular carcinoma

Value of Midkine as a Diagnostic Serum Marker in Hepatocellular Carcinoma

Evaluation of Serum Midkine as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients

Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma

Evaluation of serum Midkine as a Diagnostic Marker for Hepatocellular Carcinoma in Hepatitis C virus Patients with Liver Cirrhosis

VALUE OF SERUM MIDKINE LEVEL IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA

MOLECULAR EVALUATION OF MIDIKINE (MDK) AS A POTENTIAL BIOMARKER TODETECT HEPATOCELLULAR CARCINOMA

Serum Dickkopf-1 as A Biomarker for The Diagnosis and Prognosis of Hepatocellular Carcinoma

Significance of Serum Hepatocyte Growth Factor Level in Diagnosis of Hepatocellular Carcinoma

Clinical Significance of Serum Angiopoietin 2 in Patients with Hepatocellular Carcinoma